Physician profile
Meari Taguchi
NPI 1255838454
$1,323.47
in general payments reported to CMS, 2019-2025
8 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $228 · 2024: $269 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $634.28 | 2024-2025 | Tepezza, Uplizna |
| Pfizer INC. | $219.08 | 2025 | |
| Alexion Pharmaceuticals, INC. | $124.99 | 2023 | |
| Argenx US, INC. | $113.56 | 2025 | Vyvgart Hytrulo |
| Horizon Therapeutics Plc | $103.27 | 2023 | Tepezza |
| Teva Pharmaceuticals USA, INC. | $75.02 | 2025 | Ajovy |
| Ucb, INC. | $34.36 | 2024 | Zilbrysq |
| Dompe US, INC. | $18.91 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meari Taguchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.